AbbVie
ABBV
#31
Rank
โ‚น42.014 T
Marketcap
โ‚น23,780
Share price
-1.21%
Change (1 day)
50.76%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total debt

Total debt on the balance sheet as of March 2026 : โ‚น6.896 Trillion

According to AbbVie's latest financial reports the company's total debt is โ‚น6.896 Trillion. A companyโ€™s total debt is the sum of all current and non-current debts.

AbbVie - Total debt on balance sheet (from 2011 to 2026)

Total debt by year

Year Total debt Change
2025-12-31โ‚น6.059 T5.19%
2024-12-31โ‚น5.760 T16.51%
2023-12-31โ‚น4.943 T-5.58%
2022-12-31โ‚น5.235 T-8.27%
2021-12-31โ‚น5.707 T-9.31%
2020-12-31โ‚น6.293 T32.26%
2019-12-31โ‚น4.758 T68.82%
2018-12-31โ‚น2.818 T18.13%
2017-12-31โ‚น2.385 T-4.7%
2016-12-31โ‚น2.503 T18.95%
2015-12-31โ‚น2.104 T121.73%
2014-12-31โ‚น949.21 B4.36%
2013-12-31โ‚น909.58 B6%
2012-12-31โ‚น858.08 B33693.67%
2011-12-31โ‚น2.53 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
โ‚น6.032 T-12.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น4.104 T-40.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น5.425 T-21.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น621.08 B-90.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น2.098 T-69.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น4.394 T-36.28%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น3.210 T-53.45%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น2.388 T-65.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น38.44 B-99.44%๐Ÿ‡บ๐Ÿ‡ธ USA